八十多岁患者的外科动脉置换:单中心外科手术周围结果和五年生存率
Tiago R Velho1, João Gonçalves2, Rafael Maniés Pereira3
1Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universitário Lisboa Norte, EPE, Lisbon, Portugal; Cardiothoracic Surgery Research Unit, Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Innate Immunity and Inflammation Laboratory, Instituto Gulbenkian de Ciência, Oeiras, Portugal.
概括
八岁以上患者的动脉置换手术 (SAVR) 显示,中高风险患者的死亡率较低,但并发症率较高. 对于接受SAVR的低风险老年人来说,长期存活期长达五年是有利的.
科学领域:
- 心脏病学 心脏病学
- 老年医学 老年医学
- 外科手术的结果
背景情况:
- 大动脉狭窄是最常见的膜心脏病.
- 由于寿命更长,接受干预的80岁以上人群正在增加.
研究的目的:
- 在八十岁的患者中,评估外科动脉置换术 (SAVR) 后的术后结果和长期存活率.
- 为了比较低手术风险 (EuroscoreII <4%) 和中等高风险 (EuroscoreII ≥4%) 患者之间的结果.
主要方法:
- 对195名年龄≥80岁,接受SAVR治疗的患者进行了回顾性观察性单中心队列研究 (2017-2021).
- 患者分为低 (EuroscoreII <4%) 和中等高 (EuroscoreII ≥4%) 的风险组.
- 统计分析包括威尔科克森等级总和测试,千二测试,卡普兰-梅尔生存分析和日志等级测试.
主要成果:
- 总体中位数年龄为82岁;23.6%的EuroscoreII ≥4%.
- 在中高风险组中,并发症发生的频率更高,血液动力学支持,急性损伤和血液制品使用最常见.
- 住院时间的中位数分别为3天和6天. 五年生存率总体为75.4%,低风险组的比例更高.
结论:
- 八十多岁的SAVR与低的住院死亡率有关,但并发症的发生率显著.
- 对于八十岁的人来说,长期存活至SAVR后五年是可以接受的,特别是那些手术风险较低的人.
关键词:
大动脉门的更换大动脉门狭窄症心脏外科手术是什么心脏手术这是心脏手术.年长的老人.缩了心脏大脑的狭窄.他们是Idososos.八分生殖者 八分生殖者八岁生子 (英语:Octogenários) 是一个八岁生子.替换一个主动脉的门.更多相关视频
相关概念视频
Mitral Valve Prolapse II: Assessment and Management
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Mitral Stenosis III: Medical Management
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Aortic Regurgitation III: Medical Management
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...


